Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis

Stroke

Volumn 42, Issue 10, 2011, Pages 2883-2890

  Kwon, Sun U ^a   Hong, Keun Sik ^a   Kang, Dong Wha ^a   Park, Jong Moo ^c   Lee, Ju Hun ^d   Cho, Yong Jin ^b   Yu, Kyung Ho ^e   Koo, Ja Seong ^f   Wong, K S Lawrence ^g   Lee, Seung Hoon ^h   Lee, Kyung Bok ^e,i   Kim, Dong Eog ^j   Jeong, Sang Wook ^j   Bae, Hee Joon ^h   Lee, Byung Chul ^o   Han, Moon Ku ^h   Rha, Joung Ho ^k   Kim, Hahn Young ^l   Mok, Vincent C ^g   Lee, Yong Seok ^h   Kim, Gyeong Moon ^m   Suwanwela, Nijasri Charnnarong ⁿ   Yun, Sung Cheol ^a   Nah, Hyun Wook ^a   Kim, Jong S ^a   more..

^a University of Ulsan   (South Korea)

^b Inje University   (South Korea)

^c Eulji University   (South Korea)

^d Kangdong Sacred Heart Hospital   (South Korea)

^e Hallym University   (South Korea)

^f The Catholic University of Korea   (South Korea)

^g CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^h Seoul National University Hospital   (South Korea)

ⁱ Soonchunhyang University   (South Korea)

^j Dongguk University Ilsan Hospital   (South Korea)

^k Inha University Hospital   (South Korea)

^l Konkuk University   (South Korea)

^m Sungkyunkwan University   (South Korea)

ⁿ CHULALONGKORN UNIVERSITY   (Thailand)

^o NONE

more..

Author keywords

intracranial atherosclerosis; magnetic resonance angiography; platelet aggregation inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS CLOPIDOGREL; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CILOSTAZOL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BASILAR ARTERY; BASILAR ARTERY OBSTRUCTION; BRAIN ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; INTRACRANIAL ATHEROSCLEROTIC STENOSIS; LIPOPROTEIN BLOOD LEVEL; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; STENOSIS; STROKE;

AGED; AGED, 80 AND OVER; CONSTRICTION, PATHOLOGIC; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; ISCHEMIA; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; TETRAZOLES; TICLOPIDINE; TREATMENT OUTCOME;

EID: 80053303364     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.609370     Document Type: Article

References (27)

1. Gorelick P, Han J, Huang Y, Wong KS. Epidemiology. In: Kim JS, Caplan LR, Wong KS, eds. Intracranial atherosclerosis. West Sussex, UK: Wiley-Blackwell; 2008:33-44.
2. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: A large worldwide burden but a relatively neglected frontier. Stroke. 2008;39:2396-2399.
3. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
4. Kwon SU, Cho YJ, Koo JS, Bae HJ, Lee YS, Hong KS, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: The multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke. 2005;36:782-786.
5. Douglas JS Jr, Holmes DR Jr, Kereiakes DJ, Grines CL, Block E, Ghazzal ZM, et al. Coronary stent restenosis in patients treated with cilostazol. Circulation. 2005;112:2826-2832. (Pubitemid 41641677)
6. Arenillas JF, Molina CA, Montaner J, Abilleira S, Gonzalez-Sanchez MA, Alvarez-Sabin J. Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: A long-term follow-up transcranial doppler ultrasound study. Stroke. 2001;32:2898-2904. (Pubitemid 33134487)
7. Wong KS, Li H, Lam WW, Chan YL, Kay R. Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke. Stroke. 2002;33:532-536. (Pubitemid 34123401)
8. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706-1717.
9. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (match): Randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-337.
10. Steinhubl SR, Berger PB, Mann JT III, Fry ET, DeLago A, Wilmer C, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA. 2002; 288:2411-2420. (Pubitemid 35340537)
11. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345: 494-502. (Pubitemid 32758501)
12. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: The clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial. Circulation. 2005;111:2233-2240. (Pubitemid 40632440)
13. Wong KS, Chen C, Fu J, Chang HM, Suwanwela NC, Huang YN, et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): A randomised, open-label, blinded-endpoint trial. Lancet Neurol. 2010;9:489-497.
14. Feldmann E, Wilterdink JL, Kosinski A, Lynn M, Chimowitz MI, Sarafin J, et al. The stroke outcomes and neuroimaging of intracranial atherosclerosis (SONIA) trial. Neurology. 2007;68:2099-2106. (Pubitemid 46915385)
15. Korogi Y, Takahashi M, Mabuchi N, Miki H, Shiga H, Watabe T, et al. Intracranial vascular stenosis and occlusion: Diagnostic accuracy of three-dimensional, fourier transform, time-of-flight MR angiography. Radiology. 1994;193:187-193. (Pubitemid 24298022)
16. Park SW, Lee CW, Kim HS, Lee NH, Nah DY, Hong MK, et al. Effects of cilostazol on angiographic restenosis after coronary stent placement. Am J Cardiol. 2000;86:499-503.
17. Kang S, Wu Y, Li X. Effects of statin therapy on the progression of carotid atherosclerosis: A systematic review and meta-analysis. Atherosclerosis. 2004;177:433-442. (Pubitemid 39505278)
18. Underhill HR, Yuan C, Zhao XQ, Kraiss LW, Parker DL, Saam T, et al. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: A high-resolution magnetic resonance imaging trial. Am Heart J. 2008;155:584 e581-e588.
19. van der Steeg WA, Boekholdt SM, Stein EA, El-Harchaoui K, Stroes ES, Sandhu MS, et al. Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: A case-control analysis in EPICNorfolk. Ann Intern Med. 2007;146:640-648. (Pubitemid 351650519)
20. Thompson PD, Zimet R, Forbes WP, Zhang P. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol. 2002; 90:1314-1319. (Pubitemid 35449476)
21. Wang T, Elam MB, Forbes WP, Zhong J, Nakajima K. Reduction of remnant lipoprotein cholesterol concentrations by cilostazol in patients with intermittent claudication. Atherosclerosis. 2003;171:337-342. (Pubitemid 37492883)
22. Kang DW, Latour LL, Chalela JA, Dambrosia JA, Warach S. Early and late recurrence of ischemic lesion on MRI: Evidence for a prolonged stroke-prone state? Neurology. 2004;63:2261-2265. (Pubitemid 40024334)
23. Kang DW, Lattimore SU, Latour LL, Warach S. Silent ischemic lesion recurrence on magnetic resonance imaging predicts subsequent clinical vascular events. Arch Neurol. 2006;63:1730-1733. (Pubitemid 44925081)
24. Berger PB, Bhatt DL, Fuster V, Steg PG, Fox KA, Shao M, et al. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: Results from the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance (CHARISMA) trial. Circulation. 2010;121:2575-2583.
25. Uchiyama S, Demaerschalk BM, Goto S, Shinohara Y, Gotoh F, Stone WM, et al. Stroke prevention by cilostazol in patients with atherothrombosis: Meta-analysis of placebo-controlled randomized trials. J Stroke Cerebrovasc Dis. 2009;18:482-490.
26. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113: 555-563.
27. Amarenco P, Bogousslavsky J, Callahan A, III, Goldstein LB, Hennerici M, Rudolph AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-559. (Pubitemid 44202151)